Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents: OS Therapies (OSTX) – Creating Pharma Technology for Children with Cancer

Host Chris Miglino interviews CEO Paul Romness. He talks about the company going public, finishing their clinical trial and FDA approval.

Featured
Healthcare
Top Video
November 12, 2024

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: Biolargo (BLGO) – Cleantech and Life Sciences November 25, 2024
Sequire Spotlight Presents: La Rosa Holdings Corp (LRHC) – Providing Tools for Real State Agents November 25, 2024
Sequire Spotlight Presents: Moving iMage Technologies (MITQ) – Out-of-Home Entertainment Business November 20, 2024
Sequire Spotlight Presents: Spectra7 (SPVNF) – Semiconductors Enabling Higher Performance November 20, 2024
Sequire Spotlight Presents: HieFo Corporation – High Powered, High Efficiency Optical Communication November 19, 2024
Sequire Spotlight Presents: Ederra – World-First Farm-to-Body Functional Superfood Supplement November 19, 2024
Sequire Spotlight Presents: Freightos (CRGO) – A Digital Platform in the Freight Business November 14, 2024
Sequire Spotlight Presents: NewtekOne, Inc. (NEWT) – Providing Financial and Business Solutions November 12, 2024
Sequire Spotlight Presents: Beam Global (BEEM) – Sustainable Technology Innovation November 12, 2024
Sequire Spotlight Presents: NRX Pharmaceuticals Inc (NRXP) – Bringing Hope to Life July 01, 2024

Related Post

Today’s Stock Market in 2-Minutes

February 14, 2025
Wrap Unveils Managed Safety and Response (MSR) Connected Ecosystem in Virginia

February 14, 2025
ZenaTech’s ZenaDrone Subsidiary Initiates Process for Green UAS Certification for IQ Square Drone for Land Survey, Bridge Inspections, and Other US Defense Applications

February 11, 2025
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline

January 29, 2025

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.